Pregnancy Registry

National Pregnancy Registry

The National Pregnancy Registry for Atypical Antipsychotics is dedicated to evaluating the safety of atypical antipsychotic medications that may be taken by women during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders.   The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is inconclusive.

CALL TOLL-FREE: 1-866-961-2388

If you are interested in participating in the National Pregnancy Registry and would like to be contacted by our research coordinator, you can submit your contact information using our patient interest form. All information is kept strictly confidential.

Click here to download a pdf Registry poster.

Please click the following links to learn more about the Pregnancy Registry:

ABOUT THE REGISTRY

This page includes information about:

  • Who is eligible for the Registry
  • List of atypical antipsychotics being studied
  • What participation in the Registry involves
  • For Health Care Providers: How to refer a patient to the Registry
  • Registry Funding Information

RESOURCES

This page includes information about:

  • Published articles and case studies
  • Relevant posts from our blog
  • Past Women’s Mental Health Bulletin articles from the Center for Women’s Mental Health
  • Printable information about the Registry
  • Related links

RESEARCH

This page features the advertisement for the Registry


Call Toll-Free: 1-866-961-2388
Email: registry@womensmentalhealth.org
Website: www.womensmentalhealth.org/pregnancyregistry

Sponsored by: AstraZeneca, Bristol-Myers Squibb, Ortho-McNeil-Janssen, Sunovion, and Pfizer (2009-2011)